ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Cancer Screening Molecular Tools

Fengting Yan

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Insights from 2023 ESMO Annual Meeting

M. Raza Mirza

IOTA Terms and Definitions: How Should You Describe an Adnexal Mass?

International Society of Ultrasound in Obstetrics and Gynecology

C. Landolfo

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

Precision Oncology in the Management of Ovarian Cancer

Miami Cancer Institute Precision Oncology Symposium

D. Dizon

Year in Review: Ovarian Cancer

Fengting Yan

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

Update in Vulvar and Vaginal Cancer

Brian Slomovitz

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…

UChicago Medicine Annual Practice Updates in Hematology and Oncology

H. Cun

Recent Highlights in Ovarian Cancer

Total Health

B. Slomovitz

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/…

2024 ASCO® Annual Meeting Insights Hub

D. Dizon